We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.81T
1-Year Est. Return 41.13%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
+7.82%
1 Year Est. Return
+41.13%
3 Year Est. Return
+122.17%
5 Year Est. Return
+152.24%
10 Year Est. Return
+601.59%
AUM
$838B
AUM Growth
+$89B
Cap. Flow
+$36.2B
Cap. Flow %
4.32%
Top 10 Hldgs %
15.79%
Holding
6,872
New
694
Increased
2,351
Reduced
2,648
Closed
449

Sector Composition

Rank Sector Weight
1 Technology 15.61%
2 Financials 11.06%
3 Consumer Discretionary 9.77%
4 Healthcare 9.57%
5 Industrials 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HPK icon
5226
HighPeak Energy
HPK
$907M
$138K ﹤0.01%
13,435
+13,051
+3,399% +$119K
MITT
5227
TPG Mortgage Investment Trust
MITT
$215M
$138K ﹤0.01%
10,784
+10,780
+269,500% +$135K
SVOKW
5228
DELISTED
Seven Oaks Acquisition Corp. Warrant
SVOKW
0
CPB icon
5229
CALL
Campbell Soup
CPB
$6.89B
$137K ﹤0.01%
3,000
CURI icon
5230
CuriosityStream
CURI
$229M
$137K ﹤0.01%
+10,075
New +$130K
NVEC icon
5231
NVE Corp
NVEC
$590M
$137K ﹤0.01%
1,845
-1,385
-43% -$98.6K
ORMP icon
5232
Oramed Pharmaceuticals
ORMP
$180M
$137K ﹤0.01%
+10,256
New +$117K
KZR
5233
DELISTED
Kezar Life Sciences
KZR
$136K ﹤0.01%
2,500
+1,322
+112% +$75.1K
PAMT
5234
PAMT Corp
PAMT
$278M
$136K ﹤0.01%
10,276
-12,648
-55% -$183K
CZOO
5235
CALL
DELISTED
Cazoo Group Ltd
CZOO
$136K ﹤0.01%
7
-39
-85% -$779K
PRTK
5236
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$136K ﹤0.01%
19,857
+3,454
+21% +$27.9K
ADMA icon
5237
ADMA Biologics
ADMA
$2.2B
$135K ﹤0.01%
84,099
+33,643
+67% +$59.2K
CUE icon
5238
Cue Biopharma
CUE
$118M
$135K ﹤0.01%
386
+14
+4% +$5.43K
DFE icon
5239
WisdomTree Europe SmallCap Dividend Fund
DFE
$168M
$135K ﹤0.01%
1,840
-1,010
-35% -$75.3K
INVE icon
5240
Identive
INVE
$60.7M
$135K ﹤0.01%
+7,932
New +$120K
IRIX icon
5241
IRIDEX
IRIX
$14.9M
$135K ﹤0.01%
19,167
+18,433
+2,511% +$140K
NEWT icon
5242
NewtekOne
NEWT
$376M
$135K ﹤0.01%
3,865
KSICU
5243
DELISTED
Kadem Sustainable Impact Corporation Unit
KSICU
$135K ﹤0.01%
13,474
-721,361
-98% -$7.19M
PLSE icon
5244
Pulse Biosciences
PLSE
$3.13B
$134K ﹤0.01%
8,159
-21,166
-72% -$403K
HUM icon
5245
PUT
Humana
HUM
$46.9B
$133K ﹤0.01%
300
HT
5246
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
$133K ﹤0.01%
12,399
-13,121
-51% -$145K
GENI icon
5247
Genius Sports
GENI
$2.15B
$132K ﹤0.01%
+7,032
New +$139K
TMDI
5248
DELISTED
Titan Medical Inc. Ordinary Shares
TMDI
$132K ﹤0.01%
77,300
-200
-0.3% -$345
SREV
5249
DELISTED
ServiceSource International, Inc.
SREV
$132K ﹤0.01%
93,476
-174,914
-65% -$230K
BTRSW
5250
DELISTED
BTRS Holdings Inc. Warrants
BTRSW
0

Similar funds

JP Morgan Chase's Q2 2021 Portfolio in Review

As of Q2 2021, JP Morgan Chase held 6,872 positions worth $838B, up 12% from $749B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

JP Morgan Chase deployed $36.2B of net new capital in Q2 2021, opening 694 new positions and adding to 2,351 existing holdings. Its largest new stake was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 25,313,889 shares worth $358M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $1.51B trimmed.

  • JP Morgan Chase's largest Q2 2021 buy was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 25,313,889 shares worth $358M.
  • JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2021, an estimated $3.58B increase.
  • JP Morgan Chase's biggest Q2 2021 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $1.51B.
  • JP Morgan Chase fully exited INPHI CORPORATION in Q2 2021, selling an estimated $333M.
  • JP Morgan Chase's ten largest holdings make up 16% of its $838B portfolio in Q2 2021.
  • JP Morgan Chase opened 694 new positions and closed 449 in Q2 2021.
  • JP Morgan Chase's portfolio value rose 12% quarter-over-quarter to $838B.

Based on JP Morgan Chase's 13F filing for Q2 2021, filed 12 Aug 2021.